| Name | Title | Contact Details |
|---|
Pret is a winter sport helmet company based in Park City, Utah. We develop gear that reflects our demand for ultimate performance and innovation, our love of the outdoors & the people who share our passion.
An International multi-stream HR Consultancy offering customized services and Executive Recruitment to companies globally. Based in Cyprus our team at HR Innovate comprises of a UK qualified Business Psychologist, a published academic and Management expert and an international Training and Education specialist from the USA. What we aim to do is provide something truly special with our service: passion and sincerity. We will ensure that we assist clients in sourcing the highest caliber of employees and screen the best of the job seeker market. Using our extensive International networks we can headhunt and find that perfect person to join your team and guarantee your companys long-term success. We appreciate the limited time available to decision-makers and managers and we are offering to take away the overload of admin heavy work when it comes to advertising and sourcing eligible candidates for vacancies. We will advertise, screen and interview for you. You will then receive a short list of potential candidates ready and primed for interview. No fee to pay until we find you that perfect recruit. Advice and consultancy is free. We believe in transparent, cutting-edge HR and Recruitment with defined parameters and clear Job Specs, fair conditions for all and above all we are tenacious in our approach and spirit so we will not stop until we recruit for you that ideal candidate.
Verge Motorcycles develops and manufactures the worlds most advanced electric superbike. With its patented motor technology and innovative design, Verge challenges conventional ways of thinking with the clear goal of creating the worlds best electric motorcycle from the ground up. Not a motorcycle that looks like yesterday, but a motorcycle that feels like the future.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.